These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 29478949)

  • 1. Interleukin-1β, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-α levels in CSF and serum in relation to the clinical diversity of Parkinson's disease.
    Karpenko MN; Vasilishina AA; Gromova EA; Muruzheva ZM; Miliukhina IV; Bernadotte A
    Cell Immunol; 2018 May; 327():77-82. PubMed ID: 29478949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.
    Delgado-Alvarado M; Gago B; Gorostidi A; Jiménez-Urbieta H; Dacosta-Aguayo R; Navalpotro-Gómez I; Ruiz-Martínez J; Bergareche A; Martí-Massó JF; Martínez-Lage P; Izagirre A; Rodríguez-Oroz MC
    Mov Disord; 2017 Jul; 32(7):1066-1073. PubMed ID: 28548309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune factors or depression? Fatigue correlates in Parkinson's disease].
    Katsarou Z; Bostantjopoulou S; Hatzizisi O; Giza E; Soler-Cardona A; Kyriazis G
    Rev Neurol; 2007 Dec 16-31; 45(12):725-8. PubMed ID: 18075986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.
    Dursun E; Gezen-Ak D; Hanağası H; Bilgiç B; Lohmann E; Ertan S; Atasoy İL; Alaylıoğlu M; Araz ÖS; Önal B; Gündüz A; Apaydın H; Kızıltan G; Ulutin T; Gürvit H; Yılmazer S
    J Neuroimmunol; 2015 Jun; 283():50-7. PubMed ID: 26004156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
    Lanzrein AS; Johnston CM; Perry VH; Jobst KA; King EM; Smith AD
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):215-27. PubMed ID: 9772027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid inflammatory markers in amnestic mild cognitive impairment.
    Rizzi L; Roriz-Cruz M
    Geriatr Gerontol Int; 2017 Feb; 17(2):239-245. PubMed ID: 26818250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1β, IL-6, IL-10, and TNFα Single Nucleotide Polymorphisms in Human Influence the Susceptibility to Alzheimer's Disease Pathology.
    Babić Leko M; Nikolac Perković M; Klepac N; Štrac DŠ; Borovečki F; Pivac N; Hof PR; Šimić G
    J Alzheimers Dis; 2020; 75(3):1029-1047. PubMed ID: 32390629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired metabolism of kynurenine and its metabolites in CSF of parkinson's disease.
    Iwaoka K; Otsuka C; Maeda T; Yamahara K; Kato K; Takahashi K; Takahashi K; Terayama Y
    Neurosci Lett; 2020 Jan; 714():134576. PubMed ID: 31654722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment.
    Lindqvist D; Hall S; Surova Y; Nielsen HM; Janelidze S; Brundin L; Hansson O
    Brain Behav Immun; 2013 Oct; 33():183-9. PubMed ID: 23911592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Parkinson's disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-α.
    Li D; Song X; Huang H; Huang H; Ye Z
    Neurosci Lett; 2018 Sep; 683():181-184. PubMed ID: 30063943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Interleukin-1 Balance During Encephalitis Is Associated With Clinical Severity, Blood-Brain Barrier Permeability, Neuroimaging Changes, and Disease Outcome.
    Michael BD; Griffiths MJ; Granerod J; Brown D; Keir G; Wnęk M; Cox DJ; Vidyasagar R; Borrow R; Parkes LM; Solomon T
    J Infect Dis; 2016 May; 213(10):1651-60. PubMed ID: 26712949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood inflammatory markers in early Parkinson's disease.
    Kim R; Kim HJ; Kim A; Jang M; Kim A; Kim Y; Yoo D; Im JH; Choi JH; Jeon B
    J Clin Neurosci; 2018 Dec; 58():30-33. PubMed ID: 30454693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced levels of interleukin-1 receptor antagonist in the cerebrospinal fluid in patients with West syndrome.
    Haginoya K; Noguchi R; Zhao Y; Munakata M; Yokoyama H; Tanaka S; Hino-Fukuyo N; Uematsu M; Yamamoto K; Takayanagi M; Iinuma K; Tsuchiya S
    Epilepsy Res; 2009 Aug; 85(2-3):314-7. PubMed ID: 19375283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children.
    Armah HB; Wilson NO; Sarfo BY; Powell MD; Bond VC; Anderson W; Adjei AA; Gyasi RK; Tettey Y; Wiredu EK; Tongren JE; Udhayakumar V; Stiles JK
    Malar J; 2007 Nov; 6():147. PubMed ID: 17997848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function.
    Csuka E; Morganti-Kossmann MC; Lenzlinger PM; Joller H; Trentz O; Kossmann T
    J Neuroimmunol; 1999 Nov; 101(2):211-21. PubMed ID: 10580806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathy.
    Nagashima H; Morio Y; Yamane K; Nanjo Y; Teshima R
    Eur Spine J; 2009 Dec; 18(12):1946-50. PubMed ID: 19543752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.
    Lampa J; Westman M; Kadetoff D; Agréus AN; Le Maître E; Gillis-Haegerstrand C; Andersson M; Khademi M; Corr M; Christianson CA; Delaney A; Yaksh TL; Kosek E; Svensson CI
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12728-33. PubMed ID: 22802629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation in older subjects with early- and late-onset depression in the NESDO study: a cross-sectional and longitudinal case-only design.
    Rozing MP; Veerhuis R; Westendorp RGJ; Eikelenboom P; Stek M; Marijnissen RM; Oude Voshaar RC; Comijs HC; van Exel E
    Psychoneuroendocrinology; 2019 Jan; 99():20-27. PubMed ID: 30172071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and systemic release of cytokines, nerve growth factor, prostaglandin E2, and substance P in incisional wounds and serum following cesarean delivery.
    Carvalho B; Clark DJ; Angst MS
    J Pain; 2008 Jul; 9(7):650-7. PubMed ID: 18394968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
    Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
    Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.